Formalin-induced pain and μ-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice

Valentina Borghi, Barbara Przewlocka, Dominika Labuz, Marcin Maj, Obara Ilona, Flaminia Pavone

Research output: Contribution to journalArticle

Abstract

The effects of adenosine analogues on pain have been shown to depend on the subtype receptor involved as well as on the nociceptive stimuli and on the route of administration. In the first experiment of the present study intraperitoneal administration of the A1 receptor agonist N6-cyclopentyladenosine (CPA) (0.015, 0.03, 0.09, 0.15, 0.21, 0.3 mg/kg) induced dose-dependent analgesia to formalin pain in both phases characterizing the test. The A2a receptor agonist 2-[p-2-(carbonyl-ethyl)-phenyethylamino]-5′-N-ethylcarboxaminoadenosine (CGS21680) (0.025, 0.05, 0.1, 0.15 mg/kg) significantly affected behavioral responses to formalin only during the early phase. In the second experiment the interaction between adenosine and the opioid system was investigated through both behavioral and neurochemical studies. The opioid antagonist naltrexone (0.1 mg/kg) did not affect the antinociception induced by CPA (0.21 mg/kg) and CGS21680 (0.05 mg/kg). Autoradiographic studies showed that formalin administration significantly modified μ-opioid receptor density in the superficial laminae of the spinal cord and in the paracentral thalamic nucleus, contralateral to the side of formalin injection. CPA and CGS21680 counteracted these effects induced by formalin. In conclusion the present study confirms and extends the role of A1 and A2a adenosine receptors in the modulation of inflammatory pain and their interaction with the μ-opioid system, and suggests further investigation of these purinergic receptors from a therapeutic perspective.

Original languageEnglish
Pages (from-to)339-348
Number of pages10
JournalBrain Research
Volume956
Issue number2
DOIs
Publication statusPublished - Nov 29 2002

Fingerprint

Nociceptors
Opioid Receptors
Adenosine
Formaldehyde
Spinal Cord
Brain
Pain
Opioid Analgesics
Intralaminar Thalamic Nuclei
Adenosine A1 Receptors
Purinergic Receptors
Naltrexone
Narcotic Antagonists
Analgesia
Injections
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine

Keywords

  • Adenosine
  • Autoradiography
  • Behavior
  • Inflammatory pain
  • Naltrexone

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Formalin-induced pain and μ-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice. / Borghi, Valentina; Przewlocka, Barbara; Labuz, Dominika; Maj, Marcin; Ilona, Obara; Pavone, Flaminia.

In: Brain Research, Vol. 956, No. 2, 29.11.2002, p. 339-348.

Research output: Contribution to journalArticle

Borghi, Valentina ; Przewlocka, Barbara ; Labuz, Dominika ; Maj, Marcin ; Ilona, Obara ; Pavone, Flaminia. / Formalin-induced pain and μ-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice. In: Brain Research. 2002 ; Vol. 956, No. 2. pp. 339-348.
@article{1e38a42b8a9e47b1bf42b9172b5d8300,
title = "Formalin-induced pain and μ-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice",
abstract = "The effects of adenosine analogues on pain have been shown to depend on the subtype receptor involved as well as on the nociceptive stimuli and on the route of administration. In the first experiment of the present study intraperitoneal administration of the A1 receptor agonist N6-cyclopentyladenosine (CPA) (0.015, 0.03, 0.09, 0.15, 0.21, 0.3 mg/kg) induced dose-dependent analgesia to formalin pain in both phases characterizing the test. The A2a receptor agonist 2-[p-2-(carbonyl-ethyl)-phenyethylamino]-5′-N-ethylcarboxaminoadenosine (CGS21680) (0.025, 0.05, 0.1, 0.15 mg/kg) significantly affected behavioral responses to formalin only during the early phase. In the second experiment the interaction between adenosine and the opioid system was investigated through both behavioral and neurochemical studies. The opioid antagonist naltrexone (0.1 mg/kg) did not affect the antinociception induced by CPA (0.21 mg/kg) and CGS21680 (0.05 mg/kg). Autoradiographic studies showed that formalin administration significantly modified μ-opioid receptor density in the superficial laminae of the spinal cord and in the paracentral thalamic nucleus, contralateral to the side of formalin injection. CPA and CGS21680 counteracted these effects induced by formalin. In conclusion the present study confirms and extends the role of A1 and A2a adenosine receptors in the modulation of inflammatory pain and their interaction with the μ-opioid system, and suggests further investigation of these purinergic receptors from a therapeutic perspective.",
keywords = "Adenosine, Autoradiography, Behavior, Inflammatory pain, Naltrexone",
author = "Valentina Borghi and Barbara Przewlocka and Dominika Labuz and Marcin Maj and Obara Ilona and Flaminia Pavone",
year = "2002",
month = "11",
day = "29",
doi = "10.1016/S0006-8993(02)03568-0",
language = "English",
volume = "956",
pages = "339--348",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Formalin-induced pain and μ-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice

AU - Borghi, Valentina

AU - Przewlocka, Barbara

AU - Labuz, Dominika

AU - Maj, Marcin

AU - Ilona, Obara

AU - Pavone, Flaminia

PY - 2002/11/29

Y1 - 2002/11/29

N2 - The effects of adenosine analogues on pain have been shown to depend on the subtype receptor involved as well as on the nociceptive stimuli and on the route of administration. In the first experiment of the present study intraperitoneal administration of the A1 receptor agonist N6-cyclopentyladenosine (CPA) (0.015, 0.03, 0.09, 0.15, 0.21, 0.3 mg/kg) induced dose-dependent analgesia to formalin pain in both phases characterizing the test. The A2a receptor agonist 2-[p-2-(carbonyl-ethyl)-phenyethylamino]-5′-N-ethylcarboxaminoadenosine (CGS21680) (0.025, 0.05, 0.1, 0.15 mg/kg) significantly affected behavioral responses to formalin only during the early phase. In the second experiment the interaction between adenosine and the opioid system was investigated through both behavioral and neurochemical studies. The opioid antagonist naltrexone (0.1 mg/kg) did not affect the antinociception induced by CPA (0.21 mg/kg) and CGS21680 (0.05 mg/kg). Autoradiographic studies showed that formalin administration significantly modified μ-opioid receptor density in the superficial laminae of the spinal cord and in the paracentral thalamic nucleus, contralateral to the side of formalin injection. CPA and CGS21680 counteracted these effects induced by formalin. In conclusion the present study confirms and extends the role of A1 and A2a adenosine receptors in the modulation of inflammatory pain and their interaction with the μ-opioid system, and suggests further investigation of these purinergic receptors from a therapeutic perspective.

AB - The effects of adenosine analogues on pain have been shown to depend on the subtype receptor involved as well as on the nociceptive stimuli and on the route of administration. In the first experiment of the present study intraperitoneal administration of the A1 receptor agonist N6-cyclopentyladenosine (CPA) (0.015, 0.03, 0.09, 0.15, 0.21, 0.3 mg/kg) induced dose-dependent analgesia to formalin pain in both phases characterizing the test. The A2a receptor agonist 2-[p-2-(carbonyl-ethyl)-phenyethylamino]-5′-N-ethylcarboxaminoadenosine (CGS21680) (0.025, 0.05, 0.1, 0.15 mg/kg) significantly affected behavioral responses to formalin only during the early phase. In the second experiment the interaction between adenosine and the opioid system was investigated through both behavioral and neurochemical studies. The opioid antagonist naltrexone (0.1 mg/kg) did not affect the antinociception induced by CPA (0.21 mg/kg) and CGS21680 (0.05 mg/kg). Autoradiographic studies showed that formalin administration significantly modified μ-opioid receptor density in the superficial laminae of the spinal cord and in the paracentral thalamic nucleus, contralateral to the side of formalin injection. CPA and CGS21680 counteracted these effects induced by formalin. In conclusion the present study confirms and extends the role of A1 and A2a adenosine receptors in the modulation of inflammatory pain and their interaction with the μ-opioid system, and suggests further investigation of these purinergic receptors from a therapeutic perspective.

KW - Adenosine

KW - Autoradiography

KW - Behavior

KW - Inflammatory pain

KW - Naltrexone

UR - http://www.scopus.com/inward/record.url?scp=0037195576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037195576&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(02)03568-0

DO - 10.1016/S0006-8993(02)03568-0

M3 - Article

C2 - 12445704

AN - SCOPUS:0037195576

VL - 956

SP - 339

EP - 348

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -